Crossmark

Effectiveness of omalizumab as treatment of allergic pulmonary aspergillosis in patients with cystic fibrosis and asthma

Crossref DOI link: https://doi.org/10.1016/j.medcli.2022.02.008

Published Print: 2022-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Marcos, María Celeste

Erro Iribarren, Marta

Cisneros Serrano, Carolina
License Information

Text and Data Mining valid from 2022-08-01
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness of omalizumab as treatment of allergic pulmonary aspergillosis in patients with cystic fibrosis and asthma

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2022.02.008

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.